ArticleMicrobial genomics2025
Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing.
Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
During the COVID-19 pandemic, next-generation sequencing (NGS) has been instrumental for public health laboratories in tracking severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations and informing responses. Illumina systems and Oxford Nanopore Technologies (ONT) have been primary tools for NGS, each presenting unique advantages. The hybrid assembly (HA) approach, integrating short- and long-read sequencing methods, has been developed to improve genome accuracy by utilizing the combined advantages of both techniques. While HA has been used to enhance SARS-CoV-2 genome quality, its optimal applications for SARS-CoV-2 sequencing and surveillance have not been systematically studied. This study seeks to address this gap by evaluating the conditions under which HA improves SARS-CoV-2 genomic surveillance, analysing 192 samples using eight bioinformatics methods across both platforms. HA was evaluated against single-technology approaches for its genome assembly and mutation detection performance. While HA did not outperform single-technology methods in detecting unique mutations, it produced marginally more complete genomes than Illumina-based methods. Importantly, mutations identified by HA were consistently detected across all eight methodologies, demonstrating its reliability in mutation detection. Moreover, our research underlines the critical need for in-house validation of methods and exposes the limitations inherent in proprietary pipelines. Our findings suggest that an HA approach could be used as a quality control tool in genomic surveillance, particularly for improving low-quality ONT sequencing data by integrating high-quality Illumina sequencing data. However, implementing HA demands the presence of both sequencing platforms and additional resources, such as hands-on time, expensive sequencing reagents and bioinformatics know-how. A decision-tree analysis identified the percentage of trimmed ONT reads relative to total reads as crucial for HA success, emphasizing the significance of high-quality ONT reads. This comprehensive approach provides public health laboratories insights to refine genomic surveillance strategies for SARS-CoV-2, potentially influencing future research and response efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.